BioVEI Blog

BioVei will be attending the upcoming AACC event held this year in Anaheim California. Meetings are being scheduled at the EXPO on Wednesday July 28^th and Thursday July 29^th. If you are interested in meeting with the BioVei team, please contact BioVei to schedule and appointment.

Also, team members will be present at the IAFP show in Anaheim following AACC. During August 1^st – 3^rd you can visit them at booth #626 where the innovative products of Vista Enterprises Incorporated (VEI), www.vistaenterprisesinc.com, and FluoroVei LLC, www.fluorovei.com, will be displayed and demonstrated.

BioVei has started 2010 with the successful completion and awarding of a CE mark for the POC & OTC BioVei Chlamydia tests.  BioVei is proud of this achievement, along with its ISO13485 certification and looks forward to marketing its diagnostic tests to Europe and other regions of the world soon.

BioVei announces with regret, that David Wilson of BioScience Business Resources, located in the UK, is no longer acting as BioVei’s sales representative for Europe.  All sales inquiries should be sent to BioVei directly. David chose to pursue other opportunities, and BioVei wishes him well with his endeavors. 

BioVei will continue with its excellent service and assures that there will be no interruption in the relationship between BioVei and its distributors.

BioVei had a successful end to 2009 with the announcement of receiving its ISO13485 certification.  BioVei is proud to have achieved the ISO 13485 certification which is an internationally recognized standard of quality management systems for medical device manufacturers. 

BioVei will be exhibiting at MEDICA, the world forum for medicine.  The MEDICA event is held in Dusseldorf Germany from November 18th through the 21st.  Visit us at our booth located in Hall 3 in the U.S. Pavilion.  Our booth number is 3/D-29-16.  Please feel free to contact us prior to the event with any questions, or if you would like to schedule a specific meeting appointment time.  We look forward to our appearance at this popular event.

BioVei will be attending the AACC in Chicago July 21^st and 22^nd .  BioVei is meeting with several prominent distributors and other interested companies who are excited about

the new rapid testing device from BioVei.

BioVei is pleased to announce a collaboration with BioScience Business Resources, located in the UK,  to set up BioVei’s distribution network in Europe.  BioVei’s team is working closely with David Wilson, the Managing Director, of BioScience, and is happy with the initial response from various countries in Europe.  For more information, or to contact BioScience, please visit their website, www.biosciencebusinessresources.com.

BioVei is receiving interest from around the globe for its BioQuik confirmation test cards, and is currently filling an order for South Africa.  The BioQuik confirmation cards provide faster results and save money by providing confirmation from a first growth plate, thus eliminating further growth phases normally used.

BioVei’s test for Chlamydia is currently in clinical trials.  So far the results have been nearly 100% in accuracy when compared to the gold standard, PCR.  

The team at BioVei has been extremely pleased with the performance, and now with the results from patient testing confirming accurate performance, the team is looking forward to BioVei’s user friendly diagnostic device entering the world market in the very near future.

BioVei Incorporated looks forward to the New Year, 2009, and sales of its diagnostic tests to many world markets. 

BioVei anticipates the completion of clinical testing and regulatory work the first quarter of 2009.   With this in mind, several BioVei team members met with a multitude of companies from around the world at MEDICA in Dusseldorf, Germany, this past November, 2008.  The trip to MEDICA was very positive and the team appreciated the warm reception it received. 

BioVei is currently in the process of identifying distributors and establishing its world market network.  BioVei welcomes your inquiries.